| Percutaneous transluminal angioplasty of totally occluded iliac arteries in high-risk patients. | |
| | |
MedLine Citation:
|
PMID: 2948603 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Percutaneous transluminal angioplasty was performed successfully in five of six patients with complete iliac artery occlusion. All of the patients were at high risk because of various co-existing diseases. The length of occlusion ranged from 3.0 cm to 12.0 cm. No significant complications requiring surgery occurred during or after the procedures. Follow-up of patients revealed that the vessels were still patent after 3-22 months. Percutaneous transluminal angioplasty of totally occluded iliac arteries may represent the therapy of first choice even in the high-risk group. |
| | |
Authors:
|
Y Korogi; M Takahashi |
Related Documents
:
|
21722783 - Treatment strategies for carotid stenosis in patients at increased risk for surgery. 21609433 - Delayed endovascular treatment of descending aorta stent graft collapse in a patient tr... 15637083 - Prevalence of pulmonary vein disconnection after anatomical ablation for atrial fibrill... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: The British journal of radiology Volume: 59 ISSN: 0007-1285 ISO Abbreviation: Br J Radiol Publication Date: 1986 Dec |
Date Detail:
|
Created Date: 1987-03-18 Completed Date: 1987-03-18 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0373125 Medline TA: Br J Radiol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 1167-70 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Aged, 80 and over Angioplasty, Balloon* Arterial Occlusive Diseases / therapy* Female Humans Iliac Artery* Male Middle Aged Risk |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Acquired erythroenzymopathy in a monozygotic twin with acute myeloid leukemia.
Next Document: Total lymphoid irradiation of intractable rheumatoid arthritis.